Labcorp Holdings Inc. (LH)

LH Cash Flow Statement

Operating, investing, and financing cash flow analysis

LH Quarterly Cash Flow Statement (USD)

Quarterly Report	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024	09/30/2024	06/30/2024
Cash from Operations (CFO)	1.813B	191.500M	614.200M	387.200M	620.600M	18.500M	777.200M	277.300M	561.100M
Net Income	941.500M	277.800M	164.700M	261.100M	237.900M	212.800M	143.400M	169.300M	205.300M
Depreciation & Amortization	687.600M	173.300M	173.000M	171.000M	170.300M	166.800M	170.600M	161.500M	156.900M
Stock-Based Compensation	124.700M	31.700M	29.700M	29.200M	34.100M	32.800M	27.300M	27.000M	30.800M
Change in Accounts Receivable	8.779B	2.289B	2.261B	2.109B	2.121B	2.123B	1.944B	2.058B	2.089B
Change in Inventory	—	—	—	—	—	—	—	—	—
Change in Accounts Payable	—	—	—	—	—	—	—	—	—
Change in Working Capital	-434.300M	-352.900M	42.500M	-219.100M	95.200M	-444.700M	329.700M	-118.800M	103.300M
Cash from Investing	—	—	—	—	—	—	—	—	—
Capital Expenditures (CapEx)	-429.500M	-121.000M	-123.900M	-106.700M	-77.900M	-126.000M	-112.100M	-115.800M	-128.200M
Acquisitions	-730.700M	-202.200M	-258.000M	-260.500M	-10.000M	-53.500M	-43.900M	-463.700M	-33.800M
Cash from Financing	—	—	—	—	—	—	—	—	—
Debt Repayment	—	—	—	—	—	—	—	—	—
Stock Repurchased (Buybacks)	-548.000M	-98.000M	-225.000M	-25.000M	-200.000M	0.00	-75.100M	-75.000M	-100.000M
Dividends Paid	-240.300M	-61.200M	-59.300M	-59.900M	-59.900M	-61.600M	-60.100M	-60.500M	-60.400M
Free Cash Flow (FCF)	1.384B	70.500M	490.300M	280.500M	542.700M	-107.500M	665.100M	161.500M	432.900M
Net Change in Cash	611.700M	448.800M	-65.800M	-49.200M	277.900M	-1.149B	1.400M	1.252B	165.800M

LH Annual Cash Flow Statement (USD)

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Cash from Operations (CFO)	1.641B	1.586B	1.328B	1.956B	3.110B	2.135B	1.445B	1.305B
Net Income	876.500M	746.000M	418.000M	1.279B	2.377B	1.556B	823.800M	883.700M
Depreciation & Amortization	681.100M	643.500M	577.300M	537.200M	577.000M	825.000M	771.300M	552.100M
Stock-Based Compensation	125.800M	116.700M	128.700M	116.800M	132.900M	111.700M	107.000M	91.600M
Change in Accounts Receivable	2.261B	1.944B	1.913B	1.786B	2.261B	2.480B	1.544B	1.468B
Change in Inventory	—	—	—	—	—	—	—	—
Change in Accounts Payable	—	—	—	—	—	—	—	—
Change in Working Capital	-526.100M	-154.100M	-361.900M	-603.400M	-263.700M	-856.900M	-294.400M	-70.300M
Cash from Investing	—	—	—	—	—	—	—	—
Capital Expenditures (CapEx)	-434.500M	-489.900M	-453.600M	-481.900M	-460.400M	-381.700M	-400.200M	-379.800M
Acquisitions	-582.000M	-823.900M	-671.500M	-1.162B	-496.900M	-267.600M	-876.000M	-136.400M
Cash from Financing	—	—	—	—	—	—	—	—
Debt Repayment	—	—	—	—	—	—	—	—
Stock Repurchased (Buybacks)	-450.000M	-250.100M	-1.040B	-1.151B	-1.669B	-134.500M	-450.000M	-700.000M
Dividends Paid	-240.700M	-243.100M	-254.000M	-195.200M	0.00	0.00	0.00	0.00
Free Cash Flow (FCF)	1.206B	1.096B	874.100M	1.474B	2.649B	1.754B	1.044B	925.600M
Net Change in Cash	-986.400M	981.900M	106.800M	-1.043B	151.900M	983.300M	-89.300M	110.200M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Labcorp Holdings Inc.

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Burlington, NC

60,900 employees

www.labcorp.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Adam H. Schechter

View full financials